The rate of vaccination to eliminate, or at least mitigate the effects of the coronavirus on the world population is progressing at a good pace. For many citizens, Janssen vaccines are the most desired since they only need a single dose to be immunized.
Now, a new problem has arisen for the company that has nothing to do with side effects, rather with the distribution of doses. As reported by various medical sources in the United States, there are areas where the Janssen vaccine is not being administered on time and is past its expiration date.
The company has already taken action on the matter and is studying whether these dates can be extended and not have to waste hundreds of doses daily because they expire.
Expiration studies
According to Johnson & Johnson CEO Alex Gorsky, the company works hard for federal and local authorities to reach a solution on this issue. “We are working hard to do everything possible to ensure that these vaccines can be used and implemented in the best possible way,” Gorsky explained in a statement.
The positive part of this surplus of Janssen vaccines is that the company made a great effort to get more vaccines to meet the demand, the problem now is in the distribution of them.
“The distribution system becomes even more agile, more flexible, not only here in the United States, but also between states , although in fact around the world, and it will be a job that we must continue to focus on in the weeks and months to come. »Added the director of Johnson & Johnson.
Extend the expiration date
In this sense, the Oklahoma Department of Health, one of the states affected by this matter, has decided to withdraw expired vaccines while waiting for favorable studies that do not imply any additional problem when puncturing these expired doses in the population.
Likewise, Dr. Anthony Fauci, coronavirus adviser at the White House, is already in contact with the country’s FDA to determine if these expired Janssen vaccines can extend their date of action.
“The FDA is looking into that right now. We are trying to determine whether or not the date can in fact be extended and, if so, whether we can get them to use properly, either in the United States or elsewhere. This is something that the FDA is working on and analyzing very, very carefully, “explained the White House virologist on CNN.
